Essential role of NK cells in IgG therapy for experimental autoimmune encephalomyelitis.
Ontology highlight
ABSTRACT: Intravenous immunoglobulin has long been used in treating autoimmune diseases, although mechanisms remain uncertain. Activating Fcγ receptors are receptors of IgG and reported to be essential in intravenous immunoglobulin (IVIG) therapy. Therefore, we hypothesized natural killer (NK) cells, which express abundant activating Fcγ receptors, are the potential cellular target. In experimental autoimmune encephalomyelitis (EAE), we demonstrated that IgG suppressed disease development in intact, but not in NK cell depleted mice. Adoptive transfer of IgG-treated NK cell could protect mice against EAE, and suppressed interferon γ and interleukin 17 production. The percentage of CD4(+)Foxp3(+) regulatory T cells was significantly increased. The increase of regulatory T cells was also observed in Ig
SUBMITTER: Chong WP
PROVIDER: S-EPMC3618232 | biostudies-literature | 2013
REPOSITORIES: biostudies-literature
ACCESS DATA